# CareTrust REIT (NYSE:CTRE) Stock Price Target Lowered at UBS Group

Canonical page: https://sequoia-research.com/news/caretrust-reit-nyse-ctre-stock-price-target-lowered-at-ubs-group-40fb1004

Author: Sequoia Research
Published: 2026-10-17T23:22:59.695Z
Updated: 2026-10-18T00:13:08.004Z
Original source: [MarketBeat](https://www.marketbeat.com/instant-alerts/analyst-caretrust-reit-nyse-ctre-stock-price-target-lowered-at-ubs-group-2026-10-13/)
Source published: 2026-10-13T21:36:59.000Z
Type: News
Topics: REITs

UBS lowered its CareTrust REIT price target from US$48 to US$44 while keeping a Buy rating, according to MarketBeat's October 13 report citing Benzinga. Against the US$36.54 trading price used in the article, the revised target implied approximately 20.4% potential appreciation. That comparison reflects the brokerage's forecast, with no assurance of achieving it.

The same report describes a broader Moderate Buy consensus and US$43.92 average analyst target. CareTrust's portfolio centers on healthcare facilities operated by third parties; its long-term leases include arrangements assigning property taxes, insurance and maintenance to tenants.

[Read the original](https://www.marketbeat.com/instant-alerts/analyst-caretrust-reit-nyse-ctre-stock-price-target-lowered-at-ubs-group-2026-10-13/)

## Research considerations

REIT news can cover acquisitions, operating results, distributions, capital raising, and liquidity. Publicly traded and nontraded structures can have different reporting and liquidity arrangements. Identify the actual vehicle before comparing an announcement with other investments.

- Which REIT or portfolio is covered, and what period does the announcement describe?
- How do the reported figures relate to debt, operating performance, distribution coverage, and liquidity?

This Sequoia Research summary was prepared with AI assistance from the credited source. It is not independent verification of the source’s claims. The original publisher retains authorship of its reporting; follow the source link for the complete article.

## About Sequoia Research

Sequoia Research, LLC is an independent real estate investment research firm providing analysis of Delaware Statutory Trusts (DSTs), Tenant in Common (TIC) investments, Opportunity Zone Funds, and mineral rights and royalties.

Explore our reports for property and sponsor analysis, financial assumptions, risks, and comparison scorecards. News inclusion does not imply that a report on the particular investment is available.

[Investment research library](https://sequoia-research.com/sequoia-all-1031.html)
[Brokerage research](https://sequoia-research.com/sequoia-1031-dst-broker-rankings.html)
[Coverage policy](https://sequoia-research.com/news/about)
[Research disclosures and terms](https://sequoia-research.com/terms.html)